Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Observations

Performance of Glucose Dehydrogenase–and Glucose Oxidase–Based Blood Glucose Meters at High Altitude and Low Temperature

  1. Daniel Öberg, MD and
  2. Claes-Göran Östenson, MD, PHD
  1. From the Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska University Hospital, Stockholm, Sweden
  1. Address correspondence to Daniel Öberg, c/o Claes-Göran Östenson, Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska University Hospital, 171 76 Stockholm, Sweden. E-mail: daniel{at}oberg.se
Diabetes Care 2005 May; 28(5): 1261-1261. https://doi.org/10.2337/diacare.28.5.1261
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Blood glucose meters using the enzyme glucose oxidase (GO) have been proven unreliable at high altitude (1–6). A new test strip technology, based on the oxygen-insensitive enzyme glucose dehydrogenase (GD), has been utilized by some manufacturers. Our hypothesis was that since oxygen is not involved in the reaction pathway of glucose dehydrogenase, glucose dehydrogenase-based blood glucose meters would perform better than glucose oxidase-based meters at high altitude. To our knowledge, performance of glucose dehydrogenase-based meters at high altitude and low temperature has not been studied.

Five plasma-calibrated blood glucose meters were evaluated in this study, four glucose dehydrogenase based (GD1: Precision Xtra; GD2: Ascensia Contour; GD3: Accu-Chek Compact; and GD4: Freestyle) and one glucose oxidase based (GO1: OneTouch Ultra), with capillary blood samples from one of the investigators (D.Ö.).

First, all meters were tested in a hypobaric chamber at simulated altitudes (at 20°C in chronological order with ∼8-min intervals) of 0, 4,500, 2,500, and again 0 m above sea level, with normal (∼5.8-mmol/l) and high (∼16.5-mmol/l) plasma glucose values (n = 6 at all conditions). At 4,500 and 2,500 m altitude, the glucose oxidase-based meter (GO1) overestimated plasma glucose values by 15 ± 0.1% (mean ± SD) at the normal blood glucose level and 6.5 ± 0.5% at the high blood glucose level, as compared with the readings at 0 m.

Comparatively, three glucose dehydrogenase–based meters overestimated readings of normal and high blood glucose levels (GD1 by 6.5 ± 0.2 and 1.5 ± 0.7%, GD3 by 3.7 ± 0.1 and 3.5 ± 0.4%, and GD4 by 0.8 ± 0.2 and 0.8 ± 0.4%, respectively). The fourth, GD2, underestimated readings of normal and high blood glucose levels by 1.9 ± 0.2 and 4.2 ± 0.9%, respectively.

Second, the effect of temperature was tested with ∼14.6 mmol/l plasma glucose at high (25°C) and low (8°C) temperature at ground level, allowing 35 min for meters and test strips to acclimate to each temperature. Three meters underestimated, GD1 by 7.9 ± 0.6% (mean ± SD, n = 6), GD2 by 8.5 ± 0.7%, and GD4 by 9.7 ± 0.5%, and two meters overestimated, GO1 by 6.7 ± 0.9% and GD3 by 8.4 ± 0.6%, plasma glucose values at 8°C as compared with 25°C.

In addition, three glucose dehydrogenase–based meters (GD1, GD2, and GD3) were tested with blood at up to 5,895 m above sea level during the ascent of Mount Kilimanjaro, Tanzania. In the presence of both high altitude and low temperature, the meters diverged from each other. At the summit, 5,895 m above sea level, the readings of the investigator’s plasma glucose concentration were 2.8, 11.9, and 21.0 mmol/l (GD1, GD2, and GD3, respectively).

In this study, all four glucose dehydrogenase–based meters performed better than the glucose oxidase–based meter at high altitude, as hypothesized. However, at low temperature, all tested meters performed with similar magnitude of discrepancy. The glucose dehydrogenase–based meters showed a within-group variation, where GD3 alone overestimated plasma glucose levels at low temperature. GD3 determines glucose using reflectance photometry, in contrast to the other (electrochemical) blood glucose meters tested in this study. GD4 performed exceptionally well at simulated high altitude but not at low temperature and is based on coulometric measurement technology, in contrast to the other (amperometric) electrochemical meters (GD1, GD2, and GO1).

In conclusion, people with diabetes who intend to participate in activities at high altitude or, in particular, at low temperature, should be informed that blood glucose meters may give totally unreliable false low or high readings.

Footnotes

  • DIABETES CARE

References

  1. ↵
    Giordano BP, Thrash W, Hollenbaugh L, Dube WP, Hodges C, Swain A, Banion CR, Klingensmith GJ: Performance of seven blood glucose testing systems at high altitude. Diabetes Educ 15:444–448, 1989
  2. Pecchio O, Maule S, Migliardi M, Trento M, Veglio M: Effects of exposure at an altitude of 3,000 m on performance of glucose meters (Letter). Diabetes Care 23:129–131, 2000
    OpenUrl
  3. Moore K, Vizzard N, Coleman C, McMahon J, Hayes R, Thompson CJ: Extreme altitude mountaineering and type 1 diabetes: the Diabetes Federation of Ireland Kilimanjaro Expedition. Diabet Med 18:749–755, 2001
    OpenUrlCrossRefPubMedWeb of Science
  4. Piepmeier EH Jr, Hammett-Stabler C, Price ME, Kemper GB, Davis MG Jr: Atmospheric pressure effects on glucose monitoring devices (Letter). Diabetes Care 18:423–424, 1995
    OpenUrlFREE Full Text
  5. Gautier JF, Bigard AX, Douce P, Duvallet A, Cathelineau G: Influence of simulated altitude on the performance of five blood glucose meters. Diabetes Care 19:1430–1433, 1996
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Barnett C, Ryan F, Ballonoff L: Effect of altitude on the self-monitoring of blood-glucose (Abstract). Diabetes 36 (Suppl. 1):117A, 1987
    OpenUrl
PreviousNext
Back to top
Diabetes Care: 28 (5)

In this Issue

May 2005, 28(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Performance of Glucose Dehydrogenase–and Glucose Oxidase–Based Blood Glucose Meters at High Altitude and Low Temperature
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Performance of Glucose Dehydrogenase–and Glucose Oxidase–Based Blood Glucose Meters at High Altitude and Low Temperature
Daniel Öberg, Claes-Göran Östenson
Diabetes Care May 2005, 28 (5) 1261; DOI: 10.2337/diacare.28.5.1261

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Performance of Glucose Dehydrogenase–and Glucose Oxidase–Based Blood Glucose Meters at High Altitude and Low Temperature
Daniel Öberg, Claes-Göran Östenson
Diabetes Care May 2005, 28 (5) 1261; DOI: 10.2337/diacare.28.5.1261
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Weight Gain and Gestational Diabetes Mellitus Is a Sensitive Issue
  • Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules
  • Malignant Melanoma Misdiagnosed as a Diabetic Foot Ulcer
Show more Letters: Observations

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.